Classical corticosteroids and new lipid peroxidation inhibitors in the therapy of multiple organ failure (MOF).
Chiara
O
O
Istituto di Chirurgia d'Urgenza, University of Milan, Ospedale Maggiore IRCCS, Milan.
Padalino
P
P
Fattori
L
L
Ravizzini
C
C
Turconi
M G
MG
Tiberio
G
G
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016166:Free Radical Scavengers / Q000627:therapeutic use*; D006801:Humans; D007274:Injections, Intraperitoneal; D015227:Lipid Peroxidation / Q000187:drug effects*; D008775:Methylprednisolone / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000188:drug therapy* / Q000401:mortality; D011281:Pregnatrienes / Q000627:therapeutic use*; D011446:Prospective Studies; D011817:Rabbits; D016032:Randomized Controlled Trials as Topic; D012128:Respiratory Distress Syndrome / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy; D015054:Zymosan / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D016166:Free Radical Scavengers; D011281:Pregnatrienes; D015054:Zymosan; D008775:Methylprednisolone; C053355:tirilazad